NOTE
Actinomyces species predominantly belong to the facultatively anaerobic indigenous microflora of human and animal mucous membranes (i.e. oral cavity, intestinal tract and female genital tract). Many Actinomyces species are established pathogens of man and animals. Some species cause the clinically well-defined inflammatory disease termed actinomycosis, whereas some others may be involved aetiologically in a variety of diseases such as pharyngitis, urethritis, cutaneous or subcutaneous supporations and even endocarditis in humans. In addition, several Actinomyces species play a role in the complex aetiology of coronal and root caries and surface periodontal diseases. Despite the importance of Actinomyces species, it is only in recent years that clinical microbiologists have begun to fully appreciate the enormous diversity of these organisms from human\animal sources, and in the past few years a plethora of new Actinomyces and related taxa have been described (e.g. Funke et al., 1994 Funke et al., , 1997 Nikolaitchouk et al., 2000 ; Pascual Ramos et al., 1997 ; Pascual et al., 1999 ; Wu$ st et al., 1995) supplemented with 5 % horse blood at 37 mC, in air plus 5 % CO # . The strains were biochemically characterized by using the API rapid ID32Strep, API CORYNE and API ZYM systems according to the manufacturer's instructions (API bioMe! rieux). PAGE analysis of whole-cell proteins was performed as described by Pot et al. (1994) . Generated profiles were compared with a comprehensive database maintained by the CCUG. The 16S rRNA genes of the isolates were amplified by PCR and directly sequenced using a Taq Dye-Deoxy Terminator Cycle Sequencing kit (Applied Biosystems) and an automatic DNA sequencer (model 373A ; Applied Biosystems). A phylogenetic tree was constructed according to the neighbour-joining method and the stability of the groupings was estimated by bootstrap analysis (Felsenstein, 1989) . The three isolates consisted of Gram-positive, slender, straight to slightly curved rods, some of which exhibited branching. Cells were non-acid-fast and non- spore-forming. The strains grew under aerobic and anaerobic conditions and were catalase-negative. When grown on Columbia blood agar for 24 h, the colonies were small ( 1 mm in diameter), nonhaemolytic and grey in colour. Older cultures displayed fried-egg-type colony morphology. Using API systems, the isolates phenotypically closely resembled each other, producing acid from glucose, sucrose and -xylose, but not from -arabinose, -arabitol, cyclodextrin, mannitol, melibiose, melezitose, methyl β--glucopyranoside, glycogen, pullulan, raffinose, sorbitol, tagatose or trehalose. Acid production from maltose and ribose was found to be variable. Different results were obtained for acid production from lactose using the API CORYNE and API rapid ID32Strep tests. Lactose fermentation was positive with the API CORYNE test kit but negative using the API rapid ID32Strep system. Acid phosphatase, alanine phenylalanine proline arylamidase, alkaline phosphatase, cystine arylamidase (weak reaction), α-glucosidase and leucine arylamidase were produced by the isolates but tests for arginine dihydrolase, β-glucosidase, chymotrypsin, esterase C4, ester lipase C8, α-fucosidase, α-galactosidase, β-glucuronidase, glycyl tryptophan arylamidase, α-mannosidase, β-mannosidase, lipase C14, pyrrolidonyl arylamidase, pyroglutamic acid arylamidase, trypsin, valine arylamidase and urease were negative. Variable reactions were observed for β-galactosidase and pyrazinamidase. The production of N-acetyl-β-glucosaminidase was detected using the API CORYNE and API ZYM test strips but was negative with the API rapid ID32 Strep kit. All of the isolates hydrolysed hippurate but not aesculin or gelatin. They gave a negative Voges-Proskauer test. Two of the three strains reduced nitrate. The cellular morphology and biochemical reactions of the isolates were consistent with their assignment to the genus Actinomyces but did not appear to correspond to any described species. The results of a comparative analysis of whole-cell protein profiles of the unknown strains and other Actinomyces species by SDS-PAGE showed that the three isolates were highly related to each other and were distinct from recognized Actinomyces species.
The three isolates clustered together, forming a distinct group with a within-group correlation level of 70 % or more. Actinomyces hyovaginalis was the nearest neighbour to the unknown isolates, joining the latter at a correlation level of less than 55 % (data not shown). To ascertain the phylogenetic position of the unknown bacterium, comparative 16S rRNA gene sequencing was conducted. The almost complete gene sequences of two of the isolates (CCUG 42773 T and CCUG 34685) were determined and pairwise analysis showed these to be identical (1400 nucleotide bases compared). A stretch of 850 bases was also determined for CCUG 39151, which was also found to possess 100 % sequence similarity with the other two strains. Sequence database searches confirmed the unknown bacterium was most closely related to species of the genus Actinomyces. The results of neighbour-joining analysis showed that Actinomyces turicensis was the nearest relative of the unknown bacterium (Fig. 1) , displaying 96n6 % sequence similarity. However, bootstrap resampling showed that the association between the unknown bacterium and Actinomyces turicensis was not statistically significant (value 58 % for 500 tree replications).
It is apparent from both phenotypic and phylogenetic evidence that the isolates from human clinical specimens represent a hitherto unknown Actinomyces species. All three isolates were received by the CCUG as tentative Actinomyces turicensis. 16S rRNA gene sequencing clearly shows that Actinomyces turicensis is in fact the closest phylogenetic relative of the unknown clinical isolates, although a sequence divergence of 3n4 % demonstrates that the latter represent a distinct species. Actinomyces turicensis was proposed by Wu$ st et al. (1995) for some Actinomyces (Arcanobacterium) pyogenes-like organisms recovered from mixed cultures from a variety of human infections. Many isolates previously resembling and\or presumptively identified as Gardnerella vaginalis and Arcanobacterium species have subsequently been shown to correspond to Actinomyces turicensis (Vandamme et al., 1998) . Since the original description of Actinomyces Actinomyces funkei sp. nov. turicensis, this species has been isolated from a wide range of clinical samples, in some cases as the sole isolate, indicative of clinical relevance (Vandamme et al., 1998 ; Sabbe et al., 1999) . It seems unlikely that the unknown bacterium reported here has in the past been confused or misidentified with Actinomyces turicensis given their distinct phenotypic traits. The widely used API CORYNE test system is of particular value in distinguishing the unknown bacterium from Actinomyces turicensis. This test system has been shown to give very stable codes for Actinomyces turicensis [viz. 0(2)01070(2)1], which differ markedly from the codes obtained for the three unidentified clinical isolates (viz. 0130761, one strain ; 3530761, two strains). The distinct biochemical characteristics of the isolates together with molecular chemical and molecular genetic findings clearly demonstrate that the unknown bacterium merits classification as a new species, for which the name Actinomyces funkei is proposed. The description of Actinomyces funkei should facilitate the identification of this bacterium in the clinical laboratory, thereby improving information on its association with various clinical conditions and its possible pathological significance.
Description of Actinomyces funkei sp. nov.
Actinomyces funkei (fun.ke.i. N.L. gen. n. funkei of Funke, to honour Guido Funke, a contemporary German microbiologist, for his contributions to the clinical microbiology of Actinobacteria).
Cells are Gram-positive, slender, straight to slightly curved rods, some of which exhibit branching, which are non-acid-fast and non-spore-forming. Facultatively anaerobic and catalase-negative. When grown on Columbia blood agar for 24 h, colonies are small ( 1 mm in diameter), non-haemolytic and grey in colour. Using API systems, acid is produced from glucose, sucrose and -xylose, but not from -arabinose, -arabitol, cyclodextrin, mannitol, melibiose, melezitose, methyl β--glucopyranoside, glycogen, pullulan, raffinose, sorbitol, tagatose or trehalose. Acid production from lactose, maltose and ribose is variable. Acid phosphatase, alanine phenylalanine proline arylamidase, alkaline phosphatase, cystine arylamidase (weak reaction), α-glucosidase and leucine arylamidase are produced. Arginine dihydrolase, β-glucosidase, chymotrypsin, esterase C4, ester lipase C8, α-fucosidase, α-galactosidase, β-glucuronidase, glycyl tryptophan arylamidase, α-mannosidase, β-mannosidase, lipase C14, pyroglutamic acid arylamidase, pyrrolidonyl arylamidase, trypsin, valine arylamidase and urease are negative. N-Acetyl-β-glucosaminidase, β-galactosidase and pyrazinamidase may or may not be produced. Hippurate is hydrolysed but not aesculin or gelatin. Acetoin is not produced. Nitrate reduction is variable. Isolated from human clinical specimens. Habitat is not known. The type strain is CCUG 42773 T (l CIP 106713 T ).
